CORDIS
EU research results

CORDIS

English EN

Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe

Objective

Leukemias are a challenge to society and a cost factor because of their frequency in all age groups. They also serve as a model for a variety of diseases and possess exemplary relevance for basic research and patient care. Leukemia research and therapy have achieved high standards and even a leading position in several European countries with regard to clinical trials, standardization of diagnostics and molecular studies of signal transduction and gene expression. A true European world leadership, however, has not been accomplished yet due to national fragmentation of leukemia trial groups, diagnostic approaches and treatment research activities and a need for central information and communication structures.

The objective is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care.Integration will be supported by central information, communication, education and management structures. Other goals are to intensify target and drug discovery, to shorten the time period to clinical translation, to apply advanced genomics, telematics and biotechnology to therapeutic progress and to promote research relevant also for solid cancers by large clinical trials. Furthermore, metaanalyses of specific subaspects, elaboration of prognostic scores, recognition of gender specific differences, creation of uniform data sets for trials and registration, introduction of standards for diagnostics and treatment and development of evidence-based guidelines will be promoted throughout Europe. The proposed network will have the expertise and critical mass for European added value and world leadership. It will structure European research durably, spread European scientific excellence in the field of leukemias and can start immediately.

Coordinator

RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG

Address

Seminarstr. 2
Heidelberg

Germany

Administrative Contact

Rudiger HEHLMANN (Professor)

Participants (176)

Sort alphabetically

Expand all

UNIVERSITATSKLINIKUM FRANKFURT

Germany

UNIVERSITA CATTOLICA DEL SACRO CUORE

Italy

DEUTSCHE LEUKAMIE- UND LYMPHOM-HILFE E.V.

Germany

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

Germany

MEDIZINISCHE UNIVERSITAT GRAZ

Austria

UPPSALA UNIVERSITET

Sweden

UNIVERSITA DI BOLOGNA-UNITA COMPLESSA DI ISTITUTI DI CARDIOLOGIA ED EMATOLOGIA

Italy

UNIVERSITE DE POITIERS

France

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

HOSPITAL CLINIC PROVINCIAL DE BARCELONA

Spain

FUNDENI CLINICAL INSTITUTE

Romania

ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM

Netherlands

JOHANNES GUTENBERG-UNIVERSITAT MAINZ

Germany

IMPERIAL COLLEGE OF SCIENCE, MEDICINE AND TECHNOLOGY

United Kingdom

UNIVERSITY OF BASEL/UNIVERSITY HOSPITALS

Switzerland

ANKARA UNIVERSITY

Turkey

MEDICAL UNIVERSITY OF GDANSK

Poland

FAKULTNI NEMOCNICE BRNO

Czechia

AARHUS UNIVERSITY HOSPITAL

Denmark

UNIVERSITY OF NEWCASTLE UPON TYNE

United Kingdom

NATIONAL UNIVERSITY OF IRELAND, GALWAY

Ireland

UNIVERSITE VICTOR SEGALEN BORDEAUX 2

France

HELSINKI UNIVERSITY CENTRAL HOSPITAL

Finland

UNIVERSITA DEGLI STUDI DI TORINO

Italy

JAGIELLONIAN UNIVERSITY, MEDICAL COLLEGE

Poland

HOSPITAL UNIVERSITARIO DE LA PRINCESA

Spain

KLINIKUM KREUZSCHWESTERN WELS GMBH

Austria

UNIVERSITY OF BERN

Switzerland

UNIVERSITATSKLINIKUM MUNSTER

Germany

CARDIFF UNIVERSITY

United Kingdom

FUNDACION HOSPITAL UNIVERSITARIO "LA FE"

Spain

UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA

Italy

KAROLINSKA INSTITUTET

Sweden

STICHTING KATHOLIEKE UNIVERSITEIT, UNIVERSITY MEDICAL CENTRE NIJMEGEN

Netherlands

UNIVERSITAT ULM

Germany

TECHNISCHE UNIVERSITAT DRESDEN

Germany

HOPITAL AVICENNE (CHU PARIS 13)

France

MEDIZINISCHE HOCHSCHULE HANNOVER

Germany

MEDICAL UNIVERSITY OF SILESIA, KATOWICE

Poland

LES HOSPICES - CHUV

Switzerland

MEDIZINISCHE UNIVERSITAT WIEN

Austria

DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIE, UNIVERSITA DEGLI STUDI DI ROMA "LA SAPIENZA"

Italy

UNIVERSITAT LEIPZIG

Germany

VU ACADEMIC MEDICAL CENTER

Netherlands

FUND FOR MEDICAL RESEARCH DEVELOPMENT OF INFRASTRUCTURE AND HEALTH SERVICES, RAMBAM MEDICAL CENTER

Israel

NATIONAL RESEARCH CENTER FOR HEMATOLOGY

Russia

INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU

Spain

LEIDEN UNIVERSITY MEDICAL CENTER

Netherlands

UNIVERSITE PIERRE ET MARIE CURIE, PARIS 6

France

AZIENDA OSPEDALIERA-OSPEDALI RIUNITI DI BERGAMO

Italy

UNIVERSITY MEDICAL CENTRE UTRECHT

Netherlands

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

France

CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS

France

UNIVERSITY HOSPITAL CENTER, REBRO, ZAGREB

Croatia

THE MARIA SKLODOWSKA-CURIE MEMORIAL CANCER CENTER - INSTITUTE OF ONCOLOGY

Poland

INSTITUT PASTEUR

France

UNIVERSITAT KOLN

Germany

HS RIGSHOSPITALET

Denmark

UNIVERSITA VITA-SALUTE SAN RAFFAELE

Italy

INSTITUTE OF CANCER RESEARCH

United Kingdom

ROYAL BOURNEMOUTH AND CHRISTCHURCH HOSPITAL NHS TRUST

United Kingdom

UNIWERSYTET MEDYCZNY W LODZI

Poland

CENTRE HOSPITALIER UNIVERSITAIRE DE CAEN

France

ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM

Netherlands

INSTITUT CATALA D'ONCOLOGIA

Spain

ST. JOHANNES HOSPITAL DUISBURG

Germany

FONDAZIONE COLLEGIO GHISLIERI

Italy

UNIVERSITY OF DUNDEE

United Kingdom

UNIVERSITATSKLINIKUM DUSSELDORF

Germany

KING'S COLLEGE LONDON

United Kingdom

CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE

France

IRCCS POLICLINICO S. MATTEO

Italy

UNIVERSITY OF SOUTHAMPTON

United Kingdom

AZIENDA OSPEDALIERA OSPEDALE SAN MARTINO

Italy

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

UNIVERSITATSKLINIKUM FREIBURG

Germany

THE UNIVERSITY OF SHEFFIELD

United Kingdom

UNIVERSITE HENRI POINCARE NANCY 1

France

ST.MARIEN-KRANKENHAUS SIEGEN GEM. GMBH

Germany

UNIVERSIDAD DE SALAMANCA

Spain

CHARITE - UNIVERSITATSMEDIZIN BERLIN

Germany

PHILIPPS-UNIVERSITAT MARBURG

Germany

CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE, HOTEL-DIEU SAINT JAQUES

France

CHILDREN'S CANCER RESEARCH INSTITUTE

Austria

JUSTUS-LIEBIG-UNIVERSITAT, GIESSEN

Germany

LUNDS UNIVERSITET

Sweden

UNIVERSITY OF HELSINKI

Finland

QUEEN MARY UNIVERSITY OF LONDON

United Kingdom

UNIVERSITA DEGLI STUDI DI PERUGIA

Italy

UNIVERSITA DEGLI STUDI DI BARI

Italy

UNIVERSITA DEGLI STUDI DI PAVIA

Italy

UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN, CAMPUS KIEL

Germany

ODENSE UNIVERSITY HOSPITAL

Denmark

CEINGE BIOTECNOLOGIE AVANZATE S.C.A R.L.

Italy

CENTRAL MANCHESTER AND MANCHESTER CHILDREN'S UNIVERSITY HOSPITALS NHS TRUST

United Kingdom

EUROPEAN MOLECULAR BIOLOGY LABORATORY

Germany

UNIVERSITA DEGLI STUDI DI PADOVA

Italy

UNIVERSITY OF MODENA AND REGGIO EMILIA

Italy

FUNDACION DE INVESTIGACION DEL CANCER DE LA UNIVERSIDAD DE SALAMANCA

Spain

GOTEBORG UNIVERSITY

Sweden

ASSOCIATION POUR LA RECHERCHE SUR LES TRANSPLANTATIONS MEDULLAIRES

France

AKADEMIA MEDYCZNA W WARSTAWIE/MEDICAL UNIVERSITY OF WARSAW

Poland

ST. LASZLO HOSPITAL

Hungary

EBERHARD-KARLS UNIVERSITAT TUBINGEN

Germany

JULES BORDET INSTITUTE-FREE UNIVERSITY OF BRUSSELS

Belgium

THE HEBREW UNIVERSITY OF JERUSALEM

Israel

AZIENDA OSPEDALIERA SAN CAMILLO FORLANINI

Italy

UNIVERSITY OF GENOVA

Italy

UNIVERSITY COLLEGE LONDON

United Kingdom

TECHNISCHE UNIVERSITAT MUNCHEN

Germany

UNIVERSITATSKLINIKUM HAMBURG-EPPENDORF

Germany

MEGAPHARM GMBH

Germany

INNSBRUCK MEDICAL UNIVERSITY

Austria

ST. ANTONIUS HOSPITAL ESCHWEILER

Germany

IPSOGEN SAS

France

BAYERISCHE JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG

Germany

NATIONAL MEDICAL CENTER

Hungary

MLL MUNICH LEUKEMIA LABORATORY

Germany

WESTPFALZ-KLINIKUM GMBH

Germany

USTAV HEMATOLOGIE A KREVNI TRANSFUZE

Czechia

UNIVERSITATSMEDIZIN GOTTINGEN - GEORG-AUGUST-UNIVERSITAT GOTTINGEN - STIFTUNG OFFENTLICHEN RECHTS

Germany

THE UNIVERSITY OF YORK

United Kingdom

UNIVERSITA DEGLI STUDI MILANO-BICOCCA

Italy

MEDICAL FACULTY OF UNIVERSITY PALACKY IN OLOMOUC

Czechia

MEDICAL RESEARCH AND INFRASTRUCTURE FUND OF TEL AVIV SOURASKY MEDICAL CENTER

Israel

NATIONAL CENTER FOR SCIENTIFIC RESEARCH "DEMOKRITOS"

Greece

ST. PETERSBURG STATE PAVLOV MEDICAL UNIVERSITY

Russia

FEDERAL STATE ISTITUTION CENTRE FOR HEART, BLOOD AND ENDOCRINOLOGY NAMED AFTER V. A. ALMAZOV

Russia

BELARUSIAN RESAERCH CENTER FOR PEDIATRIC ONCOLOGY AND HEMATOLOGY OF MINISTRY OF HEALTH OF BELARUS

Belarus

ISTANBUL UNIVERSITY

Turkey

MASARYKOVA UNIVERZITA

Czechia

THE QUEEN`S UNIVERSITY OF BELFAST

United Kingdom

THE UNIVERSITY OF LIVERPOOL

United Kingdom

THE UNIVERSITY OF BIRMINGHAM

United Kingdom

UNIVERSITATEA DE MEDICINA SI FARMACIE "CAROL DAVILA" BUCURESTI

Romania

KRANKENHAUS DER BARMHERZIGEN SCHWESTERN LINZ BETRIEBS GMBH

Austria

VILNIUS UNIVERSITY HOSPITAL SANTARISKIU CLINICS

Lithuania

STATE INSTITUTION OF HEALTHCARE "REGIONAL CHRILDREN'S HOSPITAL # 1"

Russia

UNIVERSITY OF FLORENCE, DIPARTIMENTO DI AREA CRITICA MEDICO-CHIRURGICA

Italy

INSTITUT GUSTAVE ROUSSY

France

INSTITUTE OF HEMATOLOGY CLINICAL CENTER OF SERBIA, BELGRADE, SERBIA

UNIVERSITE DE LA MEDITERRANEE, AIX-MARSEILLE II

France

NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Norway

ONDOKUZ MAYIS UNIVERSITY MEDICAL FACULTY

Turkey

LABDIA LABORDIAGNOSTIK GMBH

Austria

KARAISKAKIO FOUNDATION

Cyprus

SYMBIOTEC GMBH

Germany

RIGA EASTERN CLINICAL UNIVERSITY HOSPITAL, CLINIC LINEZERS, NATIONAL HAEMATOLOGY CENTRE

Latvia

INSTITUTO PORTUGUES DE ONCOLOGIA FRANCISCO GENTIL DE LISBOR

Portugal

JOHANNES WESLING KLINIKUM MINDEN

Germany

UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST

United Kingdom

ANTWERP UNIVERSITY HOSPITAL (UNIVERSITAIR ZIEKENHUIS ANTWERPEN)

Belgium

INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING

UNIVERSITY OF CRETE

Greece

FAKULTNI NEMOCNICE HRADEC KRALOVE

Czechia

INSTITUT PAOLI-CALMETTES

France

SI"RESEARCH CENTRE FOR RADIATION MEDICINE OF AMS OF UKRAINE"

Ukraine

UNIVERSITY MEDICAL CENTRE LJUBLJANA

Slovenia

FAKULTNA NEMOCNICA S POLIKLINIKOU BRATISLAVA

Slovakia

UNIVERSITY HOSPITAL REGENSBURG

Germany

CENTRO HOSPITALAR DE COIMBRA, EPE

Portugal

RUSSIAN RESEARCH INSTITUTE OF HEMATOLOGY AND TRANSFUSIOLOGY

Russia

HAEMATOLOGY AND ONCOLOGY CLINIC, TARTU UNIVERSITY HOSPITAL

Estonia

SA POHJA-EESTI REGIONAALHAIGLA (FOUNDATION NORTH ESTONIA MEDICAL CENTRE)

Estonia

STATE INSTITUTION "INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSION MEDICINE OR UAMS"

Ukraine

HELLENIC SOCIETY OF HEMATOLOGY

Greece

KILNIKUM DER FRIEDRICH-SCHILLER-UNIVERSITAET JENA

Germany

CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES

France

STOCKHOLM SOUTH HOSPITAL

Sweden

TYKSLAB AT TYKS-SAPA UTILITY UNIT OF HOSPITAL DISTRICT OF SOUTHWESTERN FINLAND

Finland

UNIVERSITAETSKLINIKUM AACHEN

Germany

UNIVERSITE DE LIEGE

Belgium

ROSTOV STATE MEDICAL UNIVERSITY

Russia

HOSPICES CIVILS CE LYON

France

KOBENHAVNS UNIVERSITET

Denmark

UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ

Germany

Project information

Grant agreement ID: 503216

  • Start date

    1 January 2004

  • End date

    28 February 2011

Funded under:

FP6-LIFESCIHEALTH

  • Overall budget:

    € 32 241 600

  • EU contribution

    € 6 000 000

Coordinated by:

RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG

Germany